Katharine E. Spink
Operationeel Directeur bij Dark Horse Consulting Group, Inc.
Profiel
Katharine E.
Spink is currently the Chief Operating Officer & Managing Partner at Dark Horse Consulting Group, Inc. She previously worked as the Program Director at Cardiovascular Disease Foundation, Inc. from 2007 to 2008, as the VP-Regenerative Medicine Programs Operations at Geron Corp.
from 2003 to 2011, and as the Chief Operating Officer & Vice President at Asterias Biotherapeutics, Inc. from 2013 to 2018.
Spink received her undergraduate degree from Rice University and her doctorate from Stanford University School of Medicine.
Actieve functies van Katharine E. Spink
Bedrijven | Functie | Begin |
---|---|---|
Dark Horse Consulting Group, Inc.
Dark Horse Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Dark Horse Consulting Group, Inc. develops cell and gene therapy products. The firm offers process development, custom device development, project and program management, financing and diligence, manufacturing support and preclinical development services. The company was founded by Anthony H. Davies in 2014 and is headquartered in Campbell, CA. | Operationeel Directeur | 01-01-2018 |
Eerdere bekende functies van Katharine E. Spink
Bedrijven | Functie | Einde |
---|---|---|
ASTERIAS BIOTHERAPEUTICS INC | Operationeel Directeur | 19-01-2018 |
Cardiovascular Disease Foundation, Inc. | Corporate Officer/Principal | 01-01-2008 |
GERON CORPORATION | Operationeel Directeur | - |
Opleiding van Katharine E. Spink
Rice University | Undergraduate Degree |
Stanford University School of Medicine | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
GERON CORPORATION | Health Technology |
Bedrijven in privébezit | 3 |
---|---|
Asterias Biotherapeutics, Inc.
Asterias Biotherapeutics, Inc. BiotechnologyHealth Technology Asterias Biotherapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing and commercializing novel therapies in the emerging fields of cell therapy and regenerative medicine. Its product candidates include AST-OPC1, trial for spinal cord injuries; AST-VAC1, a patient specific cancer immunotherapy focused on acute myeloid leukemia; and AST-VAC2, a non-patient-specific cancer immunotherapy for non-small cell lung cancer. The company was founded on September 24, 2012 and is headquartered in Fremont, CA. | Health Technology |
Cardiovascular Disease Foundation, Inc. | |
Dark Horse Consulting Group, Inc.
Dark Horse Consulting Group, Inc. Miscellaneous Commercial ServicesCommercial Services Dark Horse Consulting Group, Inc. develops cell and gene therapy products. The firm offers process development, custom device development, project and program management, financing and diligence, manufacturing support and preclinical development services. The company was founded by Anthony H. Davies in 2014 and is headquartered in Campbell, CA. | Commercial Services |